(Q82910102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

tick-borne encephalitis

1 reference

Annelie Plentz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Wolfgang Jilg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tino F Schwarz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hans B Kuhr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Olaf Zent

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

9 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

853-856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

cites work

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

7 January 2021

Tick-borne flaviviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

TBE incidence versus virus prevalence and increased prevalence of the TBE virus in Ixodes ricinus removed from humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Persistence of antibodies after vaccination against tick-borne encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

Seroprotection 4 years following booster vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.082

10.1016/J.VACCINE.2008.11.082

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19071180%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference